P615 Clinical efficacy of accelerated 4-weekly vs. Conventional 8-weekly ustekinumab dosing in Inflammatory Bowel Disease: A single centre experience

Andrew R. Lloyd, Jane McCarthy, K Sugrue et al.|Journal of Crohn s and Colitis|2024

Cited by 0